Omnichannel strategies to revolutionize the healthcare professional experience
June 27, 2022 | Data, Medical science liaison, Multichannel, Sales rep, Strategy, omnichannel
Fishawack Health’s omnichannel experts unite to reveal how medical and commercial teams can build more meaningful experiences for healthcare professionals. They discuss the opportunities of omnichannel and explore how the roles of sales representatives and MSLs can evolve to drive greater personalization.
Two years into the COVID-19 pandemic, engaging with healthcare professionals about treatments has never been more difficult. Consultants, doctors, and nurses are overworked, stressed, and tired. Backlogs in hospitals show no sign of clearing.
The old multichannel approach to medical and commercial strategy is no longer as effective as it once was. Simply blitzing doctors and consultants with as much information as possible fails to drive engagement when many healthcare professionals struggle to stay on top of the information required to excel in their day-to-day jobs.
But in a world where we are slowly loosening restrictions, omnichannel marketing offers a quietly radical alternative. It involves developing more meaningful, targeted, and personalized messages that are integrated between online and in-person channels.
As a result, sales representatives and medical science liaisons (MSLs) remain critical to the planning and success of a program.
We gathered experts from our Medical and Marketing teams at Fishawack Health to discuss the potential of omnichannel for all types of biopharmaceutical firms, large and small, for engaging healthcare professionals. Our experts include Gary Lyons, Head of Strategy; Steve Galt, Head of Global Commercial; Drew Desjardins, Executive Vice President, Chief Strategy Officer; Victoria Clark, Strategy Director; and Fiona Grace, Engagement Strategist.
READ THE FULL ARTICLE HERE
This content was provided by Avalere Health
Company Details
Latest Content from Avalere Health
Avalere Health appoints new President of Medical to lead a tech-enabled future of medical affairs
Avalere Health appoints seasoned industry executive Effie Baoutis as President of Medical.
Fishawack Health becomes Avalere Health, uncovering the potential in every product and the possibilities for every patient
As a single united organization, the company seamlessly connects science and creativity, technology and data, and ability and agility to ensure patients receive life-changing innovations faster.
Industry leader Amar Urhekar joins Fishawack Health as Chief Operating Officer to integrate interdisciplinary teams across capabilities
As Chief Operating Officer, Amar will unite global teams to drive innovation, enhance client solutions, and accelerate growth.
Fishawack Health appoints Chief People Officer to spearhead integration of talent and culture across geographies
Fishawack Health welcomes Harriet Shurville to the team as Chief People Officer to spearhead integration efforts, champion diversity and inclusion, and cultivate an environment where interdisciplinary teams thrive.
Archetypes: Rethinking go-to-market expectations to drive commercial success
In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the…
Fishawack Health deepens key capabilities and builds an integrated delivery model under new Chief Marketing and Creative Officer
Polymath marketer Ryan Mason leads the newly expanded group, and Jeffrey D. Erb has been tapped to grow the media and analytics team as Chief Media Officer.
Oncology eBook: Reducing the care gap in cancer prevention, diagnosis, and treatment
Despite significant innovation in the oncology landscape, there is a growing care gap preventing patients accessing and benefiting from innovations in cancer treatment. In this new publication, our oncology experts…
The challenges of reimbursement and innovative pricing for cell and gene therapies
Our policy and market access experts at Avalere, part of Fishawack Health, share insights on the reimbursement challenges for cell and gene therapies and discuss the challenges and opportunities of…
Digital therapeutics as a combination therapy: Maximizing asset value and therapeutic outcomes
Digital therapeutics can increase the value of medicinal assets, driving differentiation and improving outcomes for patients. But are manufacturers prepared to capitalize on this significant untapped opportunity before the tech…
Fishawack Health welcomes Mario Muredda as its new President of Marketing
Fishawack Health (FH) ushers in a new era of data-driven omnichannel marketing with the hire of healthcare marketing veteran Mario Muredda.